Clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions.
- Year invested 2019
- Investment Stage Public/PIPES
- Sectors
- Investment Status Historic
- Associated Team
- Website xenon-pharma.com/
- Company Status IPO/Public